South Australian Venture Capital Fund
VC Fund
Adelaide, Australia
South Australian Venture Capital Fund is a VC fund in Adelaide focused on Health Care and Biotechnology. South Australian Venture Capital Fund (SAVCF) is available to help build dynamic and innovative early-stage companies to accelerate their growth. SAVCF enable innovative SA ventures to secure funding and accelerate growth into national and global markets, stimulating economic activity and job creation.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries South Australian Venture Capital Fund invests in
Stages South Australian Venture Capital Fund invests in
Countries South Australian Venture Capital Fund invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
2 more contacts available
Round size
- Seed
- $1M–$12M
- Series A
- $2.3M–$20M
- Series B
- $13M–$26M
Investment Focus
Industry
- Health Care 3 (23%)
- Biotechnology 3 (23%)
- Internet of Things 2 (15%)
- Telecommunications 2 (15%)
- Artificial Intelligence 2 (15%)
Stage
- Seed 3 (23%)
- Series B 3 (23%)
- Series A 2 (15%)
- Venture - Series Unknown 2 (15%)
- Pre-Seed 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
David Rohrsheim
Portfolio Manager
|
Portfolio Manager | Total investments: 1 | Find email | |
Peter Malinauskas
Premier of South Australia
|
Premier of South Australia | Total investments: 1 | Find email | |
Susan Close
Deputy Premier
|
Deputy Premier | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ferronova
|
Ferronova is a medical device company that offers imaging and surgery products. | $6M / Series A / Dec 16, 2025 | |
Seonix Bio
|
Seonix Bio aims to improve the treatment and prevention of blinding eye disease by developing advanced risk prediction tools. | Venture - Series Unknown / Jan 01, 2024 | |
Pearler.AI
|
Pearler.AI is a software company that provides business development including advanced Ai, and software security. | $212.1K / Pre-Seed / Aug 28, 2023 | |
Fivecast
|
Fivecast was spun out of the Data to Decisions Cooperative Research Centre, a collaboration between Australia's national security agencies and various research organisations. Fivecast and Data to Decisions CRC spent considerable effort working with the law enforcement and national security community to define the big data problems faced bythe industry. This collaboration, in line with Fivecast’s expertise in big data, natural language processing, knowledge mining and multimedia understanding, led to the development of the first commercial product, Fivecast Insight. This platform is a world-first data collection and analysis platform, powered by machine learning. | $19.9M / Series A / Apr 10, 2023 | |
Rumin8
|
Rumin8 is tackling one of the biggest contributors to climate change: methane emissions from livestock. The digestive process of beef and dairy cattle accounts for a full 3.7% of all greenhouse gas emissions, a huge contribution from a single source. With billions of people around the world relying on animal proteins as part of their daily diet,eliminating livestock methane production is a powerful lever in the quest toward a climate-optimal future.Rumin8 has invented a technology that has been shown to reduce the emissions from cattle by up to 95%. Our technology productizes the anti-methane compounds that occur naturally in plants and turns them into dietary supplements for livestock. The results are a reduction in methane emissions by up to 95%, increase in efficiency of the animal’s digestive systems, and more energy for the animal to growWe are on a mission to decarbonize hundreds of millions of cattle around the world so the global food system can take a giant step forward. | $12M / Seed / Jan 23, 2023 | |
ValAi
|
ValAi is a startup disruptive technology company that provides blockchain solutions. | $1M / Seed / Dec 13, 2022 | |
BiomeBank
|
BiomeBank is a clinical stage biotechnology company developing microbial therapies to treat unmet medical need globally, with an immediate focus on the APAC region. We currently manufacture a microbial therapy to treat Clostridoides difficile, a potentially life threatening infection, and are positioning the drug product for multiple indications.Furthermore, we are actively developing second generation therapies in multiple diseases, including Ulcerative Colitis and Crohn's Disease. | $7.3M / Venture - Series Unknown / Dec 08, 2022 | |
Kindship
|
Kindship is a social networking app built by and exclusively for parents raising children with disabilities, delays, and neurodiversity. | $1M / Seed / Nov 17, 2022 | |
Fleet Space Technologies
|
Fleet is an agile space company connecting the Internet of Things around the world using a massive fleet of small low-cost satellites. We’re making it faster, simpler and cheaper to connect the world’s devices.We provide direct, global access to a secure low-cost low-bandwidth connectivity platform ideal for machine to machine data exchange anddeploying IoT sensor networks at scale. With simple device setup and management through a web interface and powerful cognitive analytics built in, the IoT is about to take a giant leap forward.Our mission is to Connect Everything using cutting-edge communications and space technologies to maximize the resource efficiency of human civilization and enable the next industrial revolution with our free, ubiquitous connectivity platform. | $26.3M / Series B / Nov 16, 2021 | |
Lumary
|
SaaS platform for NDIS and Aged Care service providers to manage their internal workflow and business process. | $17M / Mar 29, 2021 | |
| See all 13 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does South Australian Venture Capital Fund invest in?
South Australian Venture Capital Fund invests primarily in Health Care, Biotechnology and Internet of Things startups, most often at Seed and Series B stage. Most of the 13 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is South Australian Venture Capital Fund's check size?
South Australian Venture Capital Fund typically joins rounds of $1M–$12M at Seed, $2.3M–$20M at Series A and $13M–$26M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds South Australian Venture Capital Fund participates in.
How do I contact South Australian Venture Capital Fund?
Public channels for South Australian Venture Capital Fund include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at South Australian Venture Capital Fund?
The team at South Australian Venture Capital Fund includes David Rohrsheim (Portfolio Manager), Peter Malinauskas (Premier of South Australia) and Susan Close (Deputy Premier). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
